NCT05822037View on ClinicalTrials.gov

CT0594CP CAR-T Cells in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia

NARecruitingINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

April 12, 2023

Primary Completion Date

April 29, 2026

Study Completion Date

April 29, 2026

Conditions
Multiple MyelomaPlasma Cell Leukemia
Interventions
BIOLOGICAL

CT0594CP

Cell injection

Trial Locations (1)

215000

RECRUITING

First Affiliated Hospital, Soochow University, Suzhou

Sponsors
All Listed Sponsors
collaborator

CARsgen Therapeutics Co., Ltd.

INDUSTRY

lead

The First Affiliated Hospital of Soochow University

OTHER